angucyclinone

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 02/01/2010 - "Induction of apoptosis by the angucyclinone antibiotic chemomicin in human tumor cells."
2.	Leukemia 03/01/2012 - "The new angucyclinone derivative showed inhibitory activities against the human cell lines HL-60 (leukemia), A549 (lung adenocarcinoma), and BEL-7402 (hepatoma) with inhibition rates of 68.2%, 55.9%, and 31.7%, respectively, at 100 µM. "
3.	Hepatocellular Carcinoma (Hepatoma) 03/01/2012 - "The new angucyclinone derivative showed inhibitory activities against the human cell lines HL-60 (leukemia), A549 (lung adenocarcinoma), and BEL-7402 (hepatoma) with inhibition rates of 68.2%, 55.9%, and 31.7%, respectively, at 100 µM. "
4.	Adenocarcinoma of Lung 03/01/2012 - "The new angucyclinone derivative showed inhibitory activities against the human cell lines HL-60 (leukemia), A549 (lung adenocarcinoma), and BEL-7402 (hepatoma) with inhibition rates of 68.2%, 55.9%, and 31.7%, respectively, at 100 µM. "

1.	Anti-Bacterial Agents (Antibiotics)